Monday, September 15, 2025

Psyched Wellness To Conduct Stability Tests On Proprietary Mushroom Extract

Psyched Wellness (CSE: PSYC) is progressing with the development of its flagship product, an extract of Amanita Muscaria. The company this morning announced that it has progressed the product to the stability testing phase.

Stability testing of the extract, known as AME-1, is to be conducted by CannaLabs, a licensed lab services firm. Stability tests are being conducted as a means of determining the shelf life and storage conditions for the extract as the company looks to ready for the eventual commercialization of the formulation.

The arrangement will also see testing methods developed for the raw inputs that are used in the extraction process to create AME-1. The process is to be used to assist the company in differentiating between other species and toxins, enabling Psyched Wellness to have a protocol for raw materials that is both safe and scientific in nature.

“After many months of pre clinical trials and other scientific work that is still ongoing, we have great confidence in our AME-1. Commencing the stability tests on the AME-1 is a big step that gets us closer to market.”

David Shisel, COO

Psyched Wellness last traded at $0.195 on the CSE.


FULL DISCLOSURE: Psyched Wellness is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Psyched Wellness on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

New Found Gold: The Strategic Maritime Resources Purchase

Amex Exploration: Revised Perron PEA Has INSANE Economics

Aris Mining: The Multi Billion Dollar Soto Norte PFS

Recommended

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Goliath Resources Hits 18.58 g/t Gold Over 5.00 Metres At Surebet

Related News

Psyched Wellness Submits Trademark For Amanita Muscaria Extract

Psyched Wellness (CSE: PSYC) is looking to build up its portfolio of intellectual property. The...

Thursday, January 21, 2021, 07:01:48 AM

Psyched Wellness Attracts Major Investment

Jeffrey Stevens, CEO & Director of Psyched Wellness (CSE: PSYC) joins us in today’s episode...

Friday, June 9, 2023, 01:30:00 PM

Psyched Wellness Sees Positive Initial Results From AME-1 Extract Study

Psyched Wellness (CSE: PSYC) this morning provided an update on its study to determine the...

Thursday, February 4, 2021, 07:33:40 AM

Psyched Wellness Increases Bought Deal To $5.5 Million

Psyched Wellness (CSE: PSYC) has increased the size of its bought deal private placement as...

Monday, January 25, 2021, 07:09:05 AM

Psyched Wellness Files Patent Application For Proprietary AME-1 Extraction Process

Psyched Wellness (CSE: PSYC) has begun the process of protecting its intellectual property. The firm...

Wednesday, March 17, 2021, 07:32:20 AM